Global Rosacea Treatment Market 2024-2028

Report
170 Pages
February 2024
Region: Global
TechNavio
ID: 5940326

The rosacea treatment market is forecasted to grow by USD 744.29 mn during 2023-2028, accelerating at a CAGR of 6.2% during the forecast period. The report on the rosacea treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing focus on personalized treatment approaches, growing awareness of rosacea leading to better diagnosis, and rising number of strategies undertaken by market vendors.

The rosacea treatment market is segmented as below:

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Route Of Administration

Topical
Oral
Injectable

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising demand for cosmetic procedures as one of the prime reasons driving the rosacea treatment market growth during the next few years. Also, rising focus on combination therapies and increasing demand for natural and gentle treatments will lead to sizable demand in the market.

The report on the rosacea treatment market covers the following areas:

Rosacea treatment market sizing
Rosacea treatment market forecast
Rosacea treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rosacea treatment market vendors that include AbbVie Inc., Aclaris Therapeutics Inc., AKUMS, Bausch Health Companies Inc., Croda International Plc, Dermata Therapeutics Inc., Galderma SA, Glenmark Pharmaceuticals Ltd., Hovione, Journey Medical Corp., LEO Pharma AS, Lupin Ltd., Maruho Co. Ltd., Mayne Pharma Group Ltd., Pfizer Inc., PruGen LLC, Sol-Gel Technologies Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Zydus Lifesciences Ltd.. Also, the rosacea treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global rosacea treatment market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global rosacea treatment market 2018 - 2022 ($ million)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Route of Administration Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ million)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Route of Administration

7.1 Market segments
Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Exhibit 50: Chart on Comparison by Route of Administration
Exhibit 51: Data Table on Comparison by Route of Administration
7.3 Topical - Market size and forecast 2023-2028
Exhibit 52: Chart on Topical - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Topical - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Topical - Year-over-year growth 2023-2028 (%)
7.4 Oral - Market size and forecast 2023-2028
Exhibit 56: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.5 Injectable - Market size and forecast 2023-2028
Exhibit 60: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Route of Administration
Exhibit 64: Market opportunity by Route of Administration ($ million)
Exhibit 65: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Russia - Market size and forecast 2023-2028
Exhibit 103: Chart on Russia - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Russia - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Russia - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Russia - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Aclaris Therapeutics Inc.
Exhibit 115: Aclaris Therapeutics Inc. - Overview
Exhibit 116: Aclaris Therapeutics Inc. - Business segments
Exhibit 117: Aclaris Therapeutics Inc. - Key news
Exhibit 118: Aclaris Therapeutics Inc. - Key offerings
Exhibit 119: Aclaris Therapeutics Inc. - Segment focus
12.4 Bausch Health Companies Inc.
Exhibit 120: Bausch Health Companies Inc. - Overview
Exhibit 121: Bausch Health Companies Inc. - Business segments
Exhibit 122: Bausch Health Companies Inc. - Key news
Exhibit 123: Bausch Health Companies Inc. - Key offerings
Exhibit 124: Bausch Health Companies Inc. - Segment focus
12.5 Croda International Plc
Exhibit 125: Croda International Plc - Overview
Exhibit 126: Croda International Plc - Business segments
Exhibit 127: Croda International Plc - Key news
Exhibit 128: Croda International Plc - Key offerings
Exhibit 129: Croda International Plc - Segment focus
12.6 Galderma SA
Exhibit 130: Galderma SA - Overview
Exhibit 131: Galderma SA - Product / Service
Exhibit 132: Galderma SA - Key news
Exhibit 133: Galderma SA - Key offerings
12.7 Glenmark Pharmaceuticals Ltd.
Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings
12.8 Journey Medical Corp.
Exhibit 137: Journey Medical Corp. - Overview
Exhibit 138: Journey Medical Corp. - Product / Service
Exhibit 139: Journey Medical Corp. - Key offerings
12.9 LEO Pharma AS
Exhibit 140: LEO Pharma AS - Overview
Exhibit 141: LEO Pharma AS - Business segments
Exhibit 142: LEO Pharma AS - Key offerings
Exhibit 143: LEO Pharma AS - Segment focus
12.10 Lupin Ltd.
Exhibit 144: Lupin Ltd. - Overview
Exhibit 145: Lupin Ltd. - Product / Service
Exhibit 146: Lupin Ltd. - Key news
Exhibit 147: Lupin Ltd. - Key offerings
12.11 Maruho Co. Ltd.
Exhibit 148: Maruho Co. Ltd. - Overview
Exhibit 149: Maruho Co. Ltd. - Product / Service
Exhibit 150: Maruho Co. Ltd. - Key offerings
12.12 Mayne Pharma Group Ltd.
Exhibit 151: Mayne Pharma Group Ltd. - Overview
Exhibit 152: Mayne Pharma Group Ltd. - Business segments
Exhibit 153: Mayne Pharma Group Ltd. - Key news
Exhibit 154: Mayne Pharma Group Ltd. - Key offerings
Exhibit 155: Mayne Pharma Group Ltd. - Segment focus
12.13 Pfizer Inc.
Exhibit 156: Pfizer Inc. - Overview
Exhibit 157: Pfizer Inc. - Product / Service
Exhibit 158: Pfizer Inc. - Key news
Exhibit 159: Pfizer Inc. - Key offerings
12.14 Sol-Gel Technologies Ltd.
Exhibit 160: Sol-Gel Technologies Ltd. - Overview
Exhibit 161: Sol-Gel Technologies Ltd. - Product / Service
Exhibit 162: Sol-Gel Technologies Ltd. - Key offerings
12.15 Taro Pharmaceutical Industries Ltd.
Exhibit 163: Taro Pharmaceutical Industries Ltd. - Overview
Exhibit 164: Taro Pharmaceutical Industries Ltd. - Product / Service
Exhibit 165: Taro Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 169: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 170: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Zydus Lifesciences Ltd.
Exhibit 171: Zydus Lifesciences Ltd. - Overview
Exhibit 172: Zydus Lifesciences Ltd. - Business segments
Exhibit 173: Zydus Lifesciences Ltd. - Key offerings
Exhibit 174: Zydus Lifesciences Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
13.5 List of abbreviations
Exhibit 181: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global rosacea treatment market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Distribution Channel ($ million)
Exhibits 47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 48: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 49: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Route of Administration
Exhibits 51: Data Table on Comparison by Route of Administration
Exhibits 52: Chart on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Topical - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Topical - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits 64: Market opportunity by Route of Administration ($ million)
Exhibits 65: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on Russia - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on Russia - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on Russia - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on Russia - Year-over-year growth 2023-2028 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2023 and 2028
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Aclaris Therapeutics Inc. - Overview
Exhibits 116: Aclaris Therapeutics Inc. - Business segments
Exhibits 117: Aclaris Therapeutics Inc. - Key news
Exhibits 118: Aclaris Therapeutics Inc. - Key offerings
Exhibits 119: Aclaris Therapeutics Inc. - Segment focus
Exhibits 120: Bausch Health Companies Inc. - Overview
Exhibits 121: Bausch Health Companies Inc. - Business segments
Exhibits 122: Bausch Health Companies Inc. - Key news
Exhibits 123: Bausch Health Companies Inc. - Key offerings
Exhibits 124: Bausch Health Companies Inc. - Segment focus
Exhibits 125: Croda International Plc - Overview
Exhibits 126: Croda International Plc - Business segments
Exhibits 127: Croda International Plc - Key news
Exhibits 128: Croda International Plc - Key offerings
Exhibits 129: Croda International Plc - Segment focus
Exhibits 130: Galderma SA - Overview
Exhibits 131: Galderma SA - Product / Service
Exhibits 132: Galderma SA - Key news
Exhibits 133: Galderma SA - Key offerings
Exhibits 134: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 135: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 136: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 137: Journey Medical Corp. - Overview
Exhibits 138: Journey Medical Corp. - Product / Service
Exhibits 139: Journey Medical Corp. - Key offerings
Exhibits 140: LEO Pharma AS - Overview
Exhibits 141: LEO Pharma AS - Business segments
Exhibits 142: LEO Pharma AS - Key offerings
Exhibits 143: LEO Pharma AS - Segment focus
Exhibits 144: Lupin Ltd. - Overview
Exhibits 145: Lupin Ltd. - Product / Service
Exhibits 146: Lupin Ltd. - Key news
Exhibits 147: Lupin Ltd. - Key offerings
Exhibits 148: Maruho Co. Ltd. - Overview
Exhibits 149: Maruho Co. Ltd. - Product / Service
Exhibits 150: Maruho Co. Ltd. - Key offerings
Exhibits 151: Mayne Pharma Group Ltd. - Overview
Exhibits 152: Mayne Pharma Group Ltd. - Business segments
Exhibits 153: Mayne Pharma Group Ltd. - Key news
Exhibits 154: Mayne Pharma Group Ltd. - Key offerings
Exhibits 155: Mayne Pharma Group Ltd. - Segment focus
Exhibits 156: Pfizer Inc. - Overview
Exhibits 157: Pfizer Inc. - Product / Service
Exhibits 158: Pfizer Inc. - Key news
Exhibits 159: Pfizer Inc. - Key offerings
Exhibits 160: Sol-Gel Technologies Ltd. - Overview
Exhibits 161: Sol-Gel Technologies Ltd. - Product / Service
Exhibits 162: Sol-Gel Technologies Ltd. - Key offerings
Exhibits 163: Taro Pharmaceutical Industries Ltd. - Overview
Exhibits 164: Taro Pharmaceutical Industries Ltd. - Product / Service
Exhibits 165: Taro Pharmaceutical Industries Ltd. - Key offerings
Exhibits 166: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 167: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 168: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 169: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 170: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 171: Zydus Lifesciences Ltd. - Overview
Exhibits 172: Zydus Lifesciences Ltd. - Business segments
Exhibits 173: Zydus Lifesciences Ltd. - Key offerings
Exhibits 174: Zydus Lifesciences Ltd. - Segment focus
Exhibits 175: Inclusions checklist
Exhibits 176: Exclusions checklist
Exhibits 177: Currency conversion rates for US$
Exhibits 178: Research methodology
Exhibits 179: Validation techniques employed for market sizing
Exhibits 180: Information sources
Exhibits 181: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global rosacea treatment market: AbbVie Inc., Aclaris Therapeutics Inc., AKUMS, Bausch Health Companies Inc., Croda International Plc, Dermata Therapeutics Inc., Galderma SA, Glenmark Pharmaceuticals Ltd., Hovione, Journey Medical Corp., LEO Pharma AS, Lupin Ltd., Maruho Co. Ltd., Mayne Pharma Group Ltd., Pfizer Inc., PruGen LLC, Sol-Gel Technologies Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising demand for cosmetic procedures.'

According to the report, one of the major drivers for this market is the growing focus on personalized treatment approaches.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AbbVie Inc.
Aclaris Therapeutics Inc.
AKUMS
Bausch Health Companies Inc.
Croda International Plc
Dermata Therapeutics Inc.
Galderma SA
Glenmark Pharmaceuticals Ltd.
Hovione
Journey Medical Corp.
LEO Pharma AS
Lupin Ltd.
Maruho Co. Ltd.
Mayne Pharma Group Ltd.
Pfizer Inc.
PruGen LLC
Sol-Gel Technologies Ltd.
Taro Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Zydus Lifesciences Ltd.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2413EUR$2,500USD£2,070GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3861EUR$4,000USD£3,312GBP

The rosacea treatment market is segmented as below:

By Distribution Channel

By Route Of Administration

By Geographical Landscape

The report on the rosacea treatment market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Rosacea Global Market Report 2024

Rosacea Treatment Market Report by Type, Drug Class, Route of Administration, Distribution Channel, End User, and Region 2024-2032

Rosacea Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Rosacea Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Rosacea - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029